Discover

KMDA
Kamada Ltd.
7.58
11 x 7.56
3 x 7.58
bid
ask
+
0.32
4.41%
undefined @ 04:00 PM
7.58 +0.00 (0.00%)
Ytd7.37%
1y3.84%
7.35
day range
7.58
6.60
52 week range
9.31
Open7.40Prev Close7.26Low7.35High7.58Mkt Cap437.32M
Vol244.40KAvg Vol51.93KEPS0.35P/E21.66Forward P/E19.52
Beta0.20Short Ratio0.94Inst. Own50.10%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1250-d Avg7.21200-d Avg7.721yr Est14.67

KMDA News

Is Kamada (KMDA) a Solid Growth Stock? 3 Reasons to Think "Yes"
zacks.com
Is Kamada (KMDA) a Solid Growth Stock? 3 Reasons to Think "Yes"

Kamada (KMDA) possesses solid growth attributes, which could help it handily outperform the market.

KMDA or PRTA: Which Is the Better Value Stock Right Now?
zacks.com
KMDA or PRTA: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KM

Wall Street Analysts Think Kamada (KMDA) Could Surge 79.06%: Read This Before Placing a Bet
zacks.com
Wall Street Analysts Think Kamada (KMDA) Could Surge 79.06%: Read This Before Placing a Bet

The consensus price target hints at a 79.1% upside potential for Kamada (KMDA). While empirical rese

Kamada Ltd. (KMDA) Q2 2026 Earnings Call Transcript
seekingalpha.com
Kamada Ltd. (KMDA) Q2 2026 Earnings Call Transcript

Kamada Ltd. (KMDA) Q2 2026 Earnings Call Transcript

Kamada (KMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com
Kamada (KMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the qua

Kamada (KMDA) Q2 Earnings and Revenues Surpass Estimates
zacks.com
Kamada (KMDA) Q2 Earnings and Revenues Surpass Estimates

Kamada (KMDA) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estim

Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
globenewswire.com
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double

REHOVOT, Israel and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE

Kamada Announces Planned Transition of Chief Financial Officer
globenewswire.com
Kamada Announces Planned Transition of Chief Financial Officer

REHOVOT, Israel, and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TAS

Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
globenewswire.com
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12,

REHOVOT, Israel, and HOBOKEN, N.J., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.

Reviewing InflaRx (NASDAQ:IFRX) and Kamada (NASDAQ:KMDA)
defenseworld.net
Reviewing InflaRx (NASDAQ:IFRX) and Kamada (NASDAQ:KMDA)

Kamada (NASDAQ: KMDA - Get Free Report) and InflaRx (NASDAQ: IFRX - Get Free Report) are both small-

benzinga.com
Kamada Signs $50M Plasma Supply Agreement With Biopharma Partner Through Texas Centers, Commercial S

Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of m

Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
globenewswire.com
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceu

REHOVOT, Israel and HOBOKEN, N.J., July 20, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.

Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting
globenewswire.com
Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting

Findings from analyses of CMV high-risk lung transplant recipients suggest CYTOGAM use is associated

Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
globenewswire.com
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory

REHOVOT, Israel and HOBOKEN, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE

Kamada Q1 Earnings Call Highlights
marketbeat.com
Kamada Q1 Earnings Call Highlights

Kamada NASDAQ: KMDA reiterated its full-year 2026 outlook after reporting first-quarter results that

Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript
seekingalpha.com
Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript

Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript

Kamada (KMDA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
zacks.com
Kamada (KMDA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the qua

Earnings Scheduled For May 13, 2026
benzinga.com
Earnings Scheduled For May 13, 2026

Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
globenewswire.com
Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Sign

Q1-2026 Revenue of $45.2 Million, up 3% Year-over-Year; Adjusted EBITDA of $11.6 Million, representi

Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics
zacks.com
Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics

Get a deeper insight into the potential performance of Kamada (KMDA) for the quarter ended March 202

Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
globenewswire.com
Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026

REHOVOT, Israel and HOBOKEN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
globenewswire.com
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

REHOVOT, Israel and HOBOKEN, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TAS

Earnings Scheduled For March 11, 2026
benzinga.com
Earnings Scheduled For March 11, 2026

Earnings Scheduled For November 10, 2025
benzinga.com
Earnings Scheduled For November 10, 2025

benzinga.com
Earnings Scheduled For May 14, 2025

benzinga.com
Earnings Scheduled For November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 1043 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday